Market News
Wednesday, April 20, 2016
BRIEF-Fibrogen says phase 2 data show Roxadustat corrected Anemia in chronic kidney disease patients before intervention with dialysis
* Promising phase 2 data show Roxadustat corrected Anemia in
chronic kidney disease patients before intervention with
dialysis
Read more
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment